tetano
Editor, Senior Moderator
Acute Med Surg
. 2020 Jun 10;7(1):e525.
doi: 10.1002/ams2.525. eCollection Jan-Dec 2020.
Persistence of Positive Severe Acute Respiratory Syndrome coronavirus-2 Reverse Transcription-Polymerase Chain Reaction Test Result for 24 Days in a Hospitalized Asymptomatic Carrier
Takahiro Uechi[SUP] 1 [/SUP], Shunsuke Nakamura[SUP] 1 [/SUP], Ryo Takeshita[SUP] 1 [/SUP], Kyoko Morino[SUP] 1 [/SUP], Ren Mizuno[SUP] 1 [/SUP], Yuki Nakagawa[SUP] 1 [/SUP], Yuna Irifukuhama[SUP] 1 [/SUP], Shiho Takada[SUP] 1 [/SUP], Hideki Teruya[SUP] 1 [/SUP], Naoto Mita[SUP] 1 [/SUP], Tomoki Nakamori[SUP] 1 [/SUP], Hirohisa Kinoshita[SUP] 1 [/SUP]
Affiliations
Abstract
Background: Several countries have imposed a mandatory 14-day period of quarantine on individuals arriving from countries considered high-risk for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. However, it is not clear how long asymptomatic patients infected with SARS-CoV-2 can be an asymptomatic carrier.
Case presentation: We experienced a case of an asymptomatic female patient infected with SARS-CoV-2 with abnormal chest computed tomography findings. She did not develop a fever during hospitalized isolation. She remained reverse transcription-polymerase chain reaction-positive for 24 days.
Conclusion: An asymptomatic patient diagnosed with SARS-CoV-2 infection remained reverse transcription-polymerase chain reaction-positive for 24 days, although she was quarantined in an isolation hospital. This finding suggests that an asymptomatic patient diagnosed with SARS-CoV-2 infection with abnormal chest computed tomography findings can be an asymptomatic carrier for more than 3 weeks.
Keywords: COVID‐19; Coronavirus infection; pandemic; pneumonia; reverse transcription–polymerase chain reaction; viral.
. 2020 Jun 10;7(1):e525.
doi: 10.1002/ams2.525. eCollection Jan-Dec 2020.
Persistence of Positive Severe Acute Respiratory Syndrome coronavirus-2 Reverse Transcription-Polymerase Chain Reaction Test Result for 24 Days in a Hospitalized Asymptomatic Carrier
Takahiro Uechi[SUP] 1 [/SUP], Shunsuke Nakamura[SUP] 1 [/SUP], Ryo Takeshita[SUP] 1 [/SUP], Kyoko Morino[SUP] 1 [/SUP], Ren Mizuno[SUP] 1 [/SUP], Yuki Nakagawa[SUP] 1 [/SUP], Yuna Irifukuhama[SUP] 1 [/SUP], Shiho Takada[SUP] 1 [/SUP], Hideki Teruya[SUP] 1 [/SUP], Naoto Mita[SUP] 1 [/SUP], Tomoki Nakamori[SUP] 1 [/SUP], Hirohisa Kinoshita[SUP] 1 [/SUP]
Affiliations
- PMID: 32528710
- PMCID: PMC7276721
- DOI: 10.1002/ams2.525
Abstract
Background: Several countries have imposed a mandatory 14-day period of quarantine on individuals arriving from countries considered high-risk for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. However, it is not clear how long asymptomatic patients infected with SARS-CoV-2 can be an asymptomatic carrier.
Case presentation: We experienced a case of an asymptomatic female patient infected with SARS-CoV-2 with abnormal chest computed tomography findings. She did not develop a fever during hospitalized isolation. She remained reverse transcription-polymerase chain reaction-positive for 24 days.
Conclusion: An asymptomatic patient diagnosed with SARS-CoV-2 infection remained reverse transcription-polymerase chain reaction-positive for 24 days, although she was quarantined in an isolation hospital. This finding suggests that an asymptomatic patient diagnosed with SARS-CoV-2 infection with abnormal chest computed tomography findings can be an asymptomatic carrier for more than 3 weeks.
Keywords: COVID‐19; Coronavirus infection; pandemic; pneumonia; reverse transcription–polymerase chain reaction; viral.